zlacker

>>giulio+(OP)
>The share of U.S. households reporting at least one user rose from about 11% in late 2023 to more than 16% by mid-2024.

I was wondering how you could get such a high impact overall. But it seems one in 6 households are on GLP-1 drugs in the US.

In my friend circle in Germany I don't even know one single person on this stuff.

It's insane to me that so many people need these to get off the processed foods killing them in the US.

>>carlmr+B5
in europe there is a social stigma around GLP-1 drugs, a lot of people considered it cheating and lazy, so a lot of people don't dare talk about their usage

>>Raed66+e6
You also forget it is expensive and in many cases not taking charge by the respective healthcare autority of the country, so it leads to less consumption.

>>u_sama+s6
It is for sure expensive (~300€ / month) but from my understanding nothing like the prices you see in the US (+2'000 $)

>>Raed66+w8
I've known several users of GLP1's. None ever paid more than $600/mo for them once the "patient assistance" programs started, and even in the very earliest days the prices I heard were never more than about $1100 if paid in cash.

So, while they are very expensive, your understanding is not reflective of the situation on the ground.